Explore groundbreaking research on the gut microbiome's role in colon cancer prediction and prevention in this 37-minute conference talk from ASM Live 2013. Learn about the significant shift in microbial populations preceding tumor onset in mouse models and discover the potential of microbiome research for diagnosing and managing various diseases. Join experts Joseph Zackular from the University of Michigan and David Relman from Stanford University as they delve into topics such as modulating colon cancer, inflammation-induced tumors, probiotics, personalized medicine, phage therapy, precision medicine, ecology, ethnic disparities, and the current state of probiotics. Gain insights into the complex relationship between gut bacteria and colon cancer, and understand the implications for future diagnostic and therapeutic approaches.